McKune John has filed 7 insider transactions across 1 company since March 2024.
Most recent transaction: a grant/award of 28800 shares of Pulmonx Corp ($LUNG) on March 01, 2024.
Activity breakdown: 0 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 1, 2024 | Pulmonx Corp | $LUNG | McKune John | INTERIM CFO | A | Common Stock | 28800 | $0.00 | 76,210.0000 | 0 | 60.75% | 0.00% |
| March 1, 2024 | Pulmonx Corp | $LUNG | McKune John | INTERIM CFO | A | Employee Stock Option (right to buy) | 14400 | $0.00 | 14,400.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2024 | Pulmonx Corp | $LUNG | McKune John | INTERIM CFO | S | Common Stock | 155 | $9.06 | 48,333.0000 | 0 | 0.32% | 0.00% |
| March 1, 2024 | Pulmonx Corp | $LUNG | McKune John | INTERIM CFO | S | Common Stock | 254 | $9.06 | 48,079.0000 | 0 | 0.53% | 0.00% |
| March 1, 2024 | Pulmonx Corp | $LUNG | McKune John | INTERIM CFO | S | Common Stock | 669 | $9.06 | 47,410.0000 | 0 | 1.39% | 0.00% |
| March 1, 2024 | Pulmonx Corp | $LUNG | McKune John | INTERIM CFO | A | Common Stock | 14400 | $0.00 | 61,810.0000 | 0 | 30.37% | 0.00% |
| March 1, 2024 | Pulmonx Corp | $LUNG | McKune John | INTERIM CFO | A | Employee Stock Option (right to buy) | 28800 | $0.00 | 28,800.0000 | 0 | 9999.99% | 0.00% |